Expression of tenascin is related to histologic malignancy and angiogenesis in B-cell non-Hodgkin's lymphomas

Leukemia and Lymphoma

Volumn 22, Issue 5-6, 1996, Pages 473-481

  Vacca, Angelo ^a   Ribatti, Domenico ^a   Fanelli, Massimo ^a   Costantino, Fortunato ^a   Nico, Beatrice ^a   Di Stefano, Rita ^a   Serio, Gabriella ^a   Dammacco, Franco ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Angiogenesis; Laminin; Non Hodgkin's lymphoma; Tenascin; Tumor progression; Type IV collagen

Indexed keywords

COLLAGEN TYPE 4; LAMININ; TENASCIN;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANGIOGENESIS; ARTICLE; B CELL LYMPHOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MICROSCOPY; MICROVASCULATURE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 0029821851     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054786     Document Type: Article

References (29)

1. Hofer, U. and Chiquet-Ehrismann, R. (1993) Tenascin variants: ligands and expression. Prog. Clin. Biol. Res., 383B, 455-64.
2. Natali, P. G., Nicotra, M. R., Bigotti, A., Botti, C., Castellani, P., Risso, A. M. and Zardi, L. (1991) Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues. Int. J. Cancer, 47, 811-6.
3. Juhasz, I., Murphy, G. F., Yan, H. C., Herlyn, M. and Albelda, S. M. (1993) Regulation of extracellular matrix proteins and integrin cell substratum adhesion receptors on epithelium during cutaneous human wound healing in vivo. Am. J. Pathol., 143, 1458-69.
4. Chiquet-Ehrismann, R. (1993) Tenascin and other adhesion-modulating proteins in cancer. Sem. Cancer Biol., 4, 301-10.
5. Rettig, W. J., Erickson, H. P., Albino, A. P. and Garin-Chesa, P. (1994) Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways. J. Cell Sci., 107, 487-97.
6. Soini, Y., Alavaikko, M. and Lehto, V.-P. (1992) Tenascin in reactive lymph nodes and in malignant lymphomas. Path. Res. Pract., 188, 1078-82.
7. Chilosi, M., Lestani, M., Benedetti, A., Montagna, L., Pedron, S., Scarpa, A., Minestrina, F., Hirohashi, S., Pizzolo, G. and Semenzato, G. (1993) Constitutive expression of tenascin in T-dependent zones of human lymphoid tissues. Am. J. Pathol., 143, 1348-55.
8. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. (1982) Cancer, 49, 2112-35.
9. Carbone, P. P., Kaplan, H. S., Musshof, K., Smithers, D. W. and Tubiana, M. (1971) Report of the committee on Hodgkin's disease staging classification. Cancer Res., 31, 1860-1.
10. Wain, S. L., Braylan, R. C. and Borowitz, M. J. (1987) Correlation of monoclonal antibody phenotyping and cellular DNA content in non-Hodgkin's lymphoma. The South-Eastern Cancer Study Group experience. Cancer, 60, 2403-11.
11. Joensuu, H., Klemi, P. J. and Jalkanen, S. (1990) Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study. Cancer, 65, 2564-71.
12. Del Vecchio, M. T., Leoncini, L., Buerki, B., Kraft, R., Megha, T., Barbini, P., Tosi, P. and Cottier, H. (1991) Diffuse centrocytic and/or centroblastic malignant non-Hodgkin's lymphomas: comparison of mitotic and pyknotic (apoptotic) indices. Int. J. Cancer, 47, 38-43.
13. Ioachim, A. L. (1994) Lymph Node Pathology. 2nd edn. Philadelphia: J. B. Lippincott Co.
14. Vacca, A., Di Loreto, M., Ribatti, D., Di Stefano, R., Gadaleta-Caldarola, G., Iodice, G., Caloro, D. and Dammacco, F. (1995) Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecule LFA-1, VLA-4, LAM-1 and CD44. Am. J. Hematol., 50, 9-14.
15. Vacca, A., Ranieri, G., Ribatti, D., Di Stefano, R., Caloro, D., Serio, G., Di Loreto, M., Silvestris, F. and Dammacco, F. (1994) Differential expression of two ICAM-1 epitopes and LFA-1 chains in B-cell non-Hodgkin's lymphomas. Eur. J. Haematol., 53, 85-92.
16. Elias, H. and Hyde, D. M. (1983) Stereological measurements of isotropic structures. In A Guide to Practical Stereology, edited by H. Elias and D. M. Hyde, pp. 25-44. Basel: Karger.
17. Ribatti, D., Vacca, A., Nico, B., Fanelli, M., Roncali, L. and Dammacco, F. (1995) Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study. Eur. J. Haematol. (in press).
18. Mukai, K., Rosai, J. and Burgdorf, W. H. C. (1980) Localization of factor VIII-related antigen in vascular endothelial cells using an immunoperoxidase method. Am. J. Surg. Pathol., 4, 273-6.
19. Miettinen, M., Lindenmayer, A. E. and Chaubal, A. (1994) Endothelial cell markers CD31, CD34 and BNH9 antibody to H-and Y-antigens. Evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Modern Pathol., 7, 82-90.
20. Barclay, A. N., Birkeland, M. L., Brown, M. H., Beyers, A. D., Davis, S. J., Somoza, C. and Williams, A. F. (1993) The Leukocyte Antigens. London: Facts Book, Academic Press.
21. Leek, R. D., Harris, A. L. and Lewis, C. E. (1994) Cytokine networks in solid human tumors: regulation of angiogenesis. J. Leukoc. Biol., 56, 423-35.
22. Vrucinic-Filipi, N. and Chiquet-Ehrismann, R. (1993) Tenascin function and regulation of expression. Symp. Soc. Exp. Biol., 47, 155-62.
23. McAuslan, B. R., Bender, V., Reilly, W. and Moss, B. A. (1985) New functions of epidermal growth factor: Stimulation of capillary endothelial cell migration and matrix dependent proliferation. Cell. Biol. Int. Rep., 9, 175-82.
24. Vacca, A., Ribatti, D., Roncali, L. and Dammacco, F. (1995) Angiogenesis in B-cell lymphoproliferative diseases. Biological and clinical studies. Leuk. Lymphoma, 20, 27-38.
25. Nicosia, R. F., Tchao, R. and Leighton, J. (1982) Histotypic angiogenesis in vitro: light microscopy, ultrastructural and autoradiographic studies. In Vitro, 18, 538-49.
26. Dvorak, H. F., Harley, V. S., Estrella, P., Brown, L., McDonach, T. and Dvorak, A. M. (1987) Fibrin containing gels induced angiogenesis. Implication for tumor stroma generation and wound healing. Lab. Invest., 57, 673-86.
27. Paku, S. and Pawelets, N. (1991) First steps of tumor related angiogenesis. Lab. Invest., 65, 334-46.
28. Soini, Y., Pääkkö, P., Nuorva, K., Kamel, D., Linnala, A., Virtanen, I. and Lehto, V.-P. (1993) Tenascin immunoreactivity in lung tumors. Am. J. Clin. Pathol., 100, 145-50.
29. Zagzag, D., Friedlander, D. R., Miller, D. C., Dosik, J., Gangiarella, J., Kostianowsky, M., Cohen, H., Grumet, M. and Greco, M. A. (1995) Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res., 55, 907-14.